Skip header and navigation

40 records – page 1 of 2.

Date Research Question / Title Unique ID Research Team
June 30, 2022 Response to Long COVID: What are the programs or accomodations to current frameworks? EOC220303 RR Table EOC
June 30, 2022 Response to Long COVID: What are the programs or accommodations to current frameworks? EOC220303 RR EOC
June 17, 2022 Response to Long COVID: programs or accommodations to current frameworks EOC220303v2 ESR EOC
May 24, 2022 When should post-COVID infected patients receive booster shots? EOC220503 RR Table EOC
May 24, 2022 When should post-COVID infected patients receive booster shots? EOC220503 RR EOC
May 13, 2022 When should post-COVID infected patients receive booster shots? EOC220503 ESR EOC
May 10, 2022 Is there an optimal interval between the administration of COVID-19 early intervention therapeutic products and COVID-19 vaccination? EOC220501 RR Table EOC
May 10, 2022 Is there an optimal interval between the administration of COVID-19 early intervention therapeutic products and COVID-19 vaccination? EOC220501 RR EOC
May 4, 2022 Is there an optimal interval between the administration of COVID-19 early intervention therapeutic products and COVID-19 vaccination? EOC220501 ESR EOC
March 11, 2022 Response to Long COVID: What are the programs or accommodations to current frameworks? EOC220303 ESR EOC
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR Table EOC
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR EOC
March 4, 2022 What is the safety/efficacy of the Novavax vaccine? EOC220302 ESR EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR Table EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
September 29, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 ESR EOC
June 24, 2021 What is the clinical management of post-acute COVID? PH210602 ESR Public Health
June 18, 2021 What healthcare delivery models or programs have been described and implemented to address post-acute COVID? PH210601 ESR Public Health
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR Table EOC

40 records – page 1 of 2.